Lallemand Pharma AG
10 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Prevention With Ismigen of RTIs in Kids (NCT07578012) | Lallemand Pharma AG | 2026-06-01 |
| Prevention With Healsea in Adults Against Respiratory Infection Study (NCT06613906) | Lallemand Pharma AG | 2024-11-29 |
| HEALSea Nasal Spray for Prevention of Infections in Children (NCT06582589) | Lallemand Pharma AG | 2024-11-25 |
| Survey of Incidence of Respiratory Tract Infections (NCT06649032) | Lallemand Pharma AG | 2023-11-07 |
| Testing the Efficacy in Adults With Cold of HEalsea Rescue* (NCT05819190) | Lallemand Pharma AG | 2022-12-14 |
| Impact of Symbiofilm On Nasal Microbiota (NCT05015530) | Lallemand Pharma AG | 2022-12-12 |
| Symbiofilm Trial in Allergic Kids (SYMBIOFILM-TAK) (NCT05034328) | Lallemand Pharma AG | 2022-02-14 |
Track Lallemand Pharma AG automatically
Every clearance here is in the API, with alerts when new ones post.